The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics
about
Introducing Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, an open access journal of the Alzheimer's AssociationLong-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.The CADM2 gene is associated with processing speed performance - evidence among elderly with Type 2 Diabetes.Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women.Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.Shorter adult height is associated with poorer cognitive performance in elderly men with type II diabetes.Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease.An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.Computerized cognitive training for older diabetic adults at risk of dementia: Study protocol for a randomized controlled trial.Statin Use is Associated with Better Cognitive Function in Elderly with Type 2 Diabetes.Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes.Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes.Cognitive and gait decrements among non-demented older adults with Type 2 diabetes or hypertension: a systematic review.Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial.Depressive Symptoms Are Associated with Cognitive Function in the Elderly with Type 2 Diabetes
P2860
Q30489394-D8E99E45-5B43-4869-9C87-FF6391A327ABQ37652814-8B4D5984-F45A-4A99-8E39-3332236341E1Q38372387-090A94C8-2CE8-4A3D-9BE8-F73364B2BA7EQ38392892-9CA1D7D9-53F4-4F0D-A917-626BAD46F311Q38403445-B5020450-49D0-487E-836B-9B294B2A5F35Q38421254-D46E47DB-2143-4047-9215-BB46697E50F9Q38743674-5732E74D-CB76-4EF9-813E-BC1A586748AAQ38830948-142BB935-0B4C-42EE-9F0A-E96EACF58A4FQ47111827-D0E5A72A-BC2B-4BA1-A1E7-59CE9F4DA603Q47151599-265F7752-4128-4BBF-8107-4EDAB143A055Q47333026-CC108BB1-4BDF-45A8-9AE4-3F93C66B93E0Q47850262-87F3F4F3-4DFC-46A3-97CC-7C514218C31DQ47874346-BCB94E1B-973C-4D50-AFFA-A2C6A7934A73Q51776703-4BBF7165-ECFC-42F6-981F-D576E0372942Q55407755-1576B3B3-CE19-469C-8BC2-A40D5A5B069CQ58727025-A28F5B40-0727-4D4A-B544-A76C91AEEF34
P2860
The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The Israel Diabetes and Cognit ...... n and baseline characteristics
@ast
The Israel Diabetes and Cognit ...... n and baseline characteristics
@en
type
label
The Israel Diabetes and Cognit ...... n and baseline characteristics
@ast
The Israel Diabetes and Cognit ...... n and baseline characteristics
@en
prefLabel
The Israel Diabetes and Cognit ...... n and baseline characteristics
@ast
The Israel Diabetes and Cognit ...... n and baseline characteristics
@en
P2093
P2860
P1476
The Israel Diabetes and Cognit ...... n and baseline characteristics
@en
P2093
Anthony Heymann
Derek Leroith
Efrat Kravitz
Erin Moshier
Hadas Hoffman
James Godbold
James Schmeidler
Jeremy M Silverman
Keren Koifman
Michal Schnaider Beeri
P2860
P304
P356
10.1016/J.JALZ.2014.06.002
P577
2014-08-20T00:00:00Z